Waters Corporation creates business advantages for laboratory-dependent organizations by delivering scientific innovation to enable customers to make significant advancements. Waters helps customers make profound discoveries, optimize laboratory operations, deliver product performance, and ensure regulatory compliance with a connected portfolio of separations and analytical science, laboratory informatics, mass spectrometry, as well as thermal analysis.
Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation in the areas of liquid chromatography and mass spectrometry, two vital enabling technologies for today’s state-of-the-art analytical laboratories.
Waters instruments and software enable significant advancements in such areas as healthcare delivery, clinical research, forensic toxicology, sports medicine, drug discovery and development, environmental management, food and beverage quality control, food safety testing, and water quality analysis worldwide.
Bringing keen understanding and deep experience to those responsible for laboratory infrastructure and performance, Waters helps its customers meet client expectations and satisfy delivery timetables, make profound discoveries, manage laboratory operations, manufacture quality products, and meet current Good Manufacturing Process (cGMP) and Good Laboratory Practice (GLP) requirements and comply with federal and international regulatory guidelines for the testing and manufacture of generic and brand name drugs.
Pioneering a connected portfolio of liquid chromatography and mass spectrometry products, laboratory consumables, laboratory informatics, and post-sale support services, Waters’ technology breakthroughs and laboratory solutions provide an enduring platform for customer success.
Contact Waters Corporation by clicking here.
Transforming sample preparation
Panel discussion: what does the future hold for biomarker R&D?
Panel discussion on large molecule quantification by LC–MS
A powerful hybrid IA-LC–MS method for the determination of insulin analogues in clinical samples
The ever-expanding role of HRMS in regulated bioanalysis: application to both small molecule and biopharmaceutical study support
Bridging the gap: connecting evolving bioanalysis expertise to a rapidly changing global biopharma industry
Webinar with the 2015 Young Investigator Award (YIA) winner
Towards standardization of high performance protein quantification workflows
Panel discussion on peptide and large molecule analysis by LC-MSInterview with Xiwei (Emmi) Zheng (winner of the 2015 YIA) and Kelly Doering (Waters Corporation) on the Young Investigator Award and the importance of supporting early career scientists
Interview with Erin Chambers (Waters Corporation): Taking the complexity out of large molecule protein quantification
Interview with Mark Wrona (Waters Corporation) on LC-MS technologies
Interview with Mary Lame (Waters Corporation) on her career at Waters and recent developments in LC-MS
Interview with Bonnie Alden (Waters Corporation) on the CORTECS columns
Interview with Erin Chambers (Waters Corporation) on the ionKey/MS system
Interview with Logan Umberger & Paul Rainville (Waters Corporation) on LC-MS for large molecule bioanalysisThe challenges of large molecule bioanalysis: an interview with John Kellie
Targeted omics library: fast forward to results with MetaboQuan
Busting Scientific Misconceptions
Xevo G2-XS QTof Mass Spectrometer: Extraordinary Possibilities for Your Everyday AnalysisAsk the Experts – HRMS: where are we now?
Bioanalysis Rising Star Award 2018
Waters: Peptide and Protein Bioanalysis Boot Camp
High sensitivity intact monoclonal antibody (mAb) HRMS quantification
Waters targeted omics library
In the Zone: biotransformation
MetaboQuan-r for bile acids in human serum: a rapid, targeted UPLC-MS/MS method for metabolomic research studies
People behind the science: who is your bioanalytical hero?
Reaching New Heights in Targeted Quantitation with HRMS (APA 2015)
Evaluation of Ion Mobility and Targeted QTof acquisition modes for the quantitative analysis of peptides (ASMS 2016)